Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-04-23-Speech-4-048"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20090423.3.4-048"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Health is becoming increasingly important in Europe, and I think that patients clearly expect greater certainty about their rights, but they also expect correct and sound information. This proposal regarding patient mobility thus comes none too soon. We have all been waiting a long time for it. It is regrettable, therefore, that the man who devoted a large part of his career to this matter must now himself be absent for health reasons, and I wholeheartedly join in expressing good wishes for John’s speedy recovery.
I wish to concentrate primarily on a number of positive points that are in the interest of the patient. The establishment of a point of contact in the patient’s home country where the latter can turn for all types of information, as well as of an ombudsman for patients, and certainly the increase in scale thanks to better cooperation between the Member States, definitely offer added value to patients, in particular to those who are suffering from a rare disease.
I think that, for the vexed question of prior approval for hospital care, a very creative compromise has been reached that is to the advantage of both the patient and the health insurer. Yet in order to keep the reverse phenomenon, that of an excessive in-flow, under control, and that is important for my region of Flanders, the report explicitly states that a hospital can never be compelled to accept patients from abroad if, as a result, its own citizens may be faced with a waiting list.
As a resident of a border region between Flanders, the Netherlands, Germany and Wallonia, I am very pleased with the request to the Commission to designate certain border regions as trial areas for innovative projects relating to cross-border healthcare. I think that the results of such a trial will be very informative for other regions. I hope that the Euregion can serve as an example in this regard."@en1
|
lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples